Loading...
Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients
BACKGROUND: Several reports suggest that vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma (mRCC) may be more toxic in Asian vs non-Asian populations. Comparative efficacy of these agents with respect to ethnicity is not well characterised. METHODS: A mult...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3960609/ https://ncbi.nlm.nih.gov/pubmed/24548864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.28 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|